Imaging Diagnostic Systems (IMDS) 10-Q 30 Sep 24 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Dec. 31, 2023	Sep. 30, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	No
Amendment Flag	false
Document Period End Date	Dec. 31, 2023
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity Information [Line Items]
Entity Registrant Name	IMAGING DIAGNOSTIC SYSTEMS, INC.
Entity Central Index Key	0000790652
Entity File Number	000-26028
Entity Tax Identification Number	22-2671269
Entity Incorporation, State or Country Code	FL
Current Fiscal Year End Date	--06-30
Entity Current Reporting Status	No
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	618 E South St
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32801
Entity Phone Fax Numbers [Line Items]
City Area Code	(954)
Local Phone Number	581-9800
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		123,156,941

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current assets:
Cash	$ 142	$ 1,088
Royalty receivable		10,610
Prepaid expenses and deposits	10,053	10,053
Total current assets	10,218	21,751
Total assets	10,218	21,751
Current liabilities:
Accounts payable and accrued expenses	981,457	946,069
Accrued payroll taxes and penalties	314,019	314,019
PPP loan payable	72,930	72,930
Total current liabilities	2,136,838	2,096,667
Commitment and Contingencies (Note 16)
Temporary equity
Total temporary equity	461,013	451,939
Stockholders’ Deficit:
Preferred stock, no par, 2,000,000 shares authorized Convertible preferred stock, Series M, 600 designated 0 shares issued and outstanding at December 31, 2023 and June 30, 2023
Common stock, no par value, 500,000,000 shares authorized, 123,156,941 and 123,156,941 shares issued and outstanding December 31, 2023 and June 30, 2023, respectively	133,346,959	133,346,959
Accumulated Deficit	(135,934,592)	(135,873,814)
Total stockholders’ deficit	(2,587,633)	(2,526,855)
Total liabilities and stockholders’ deficit	10,218	21,751
Related Party
Current assets:
Due from related party, net of allowance	23
Current liabilities:
Promissory notes, related parties	768,432	763,649
Convertible Preferred Series L
Temporary equity
Total temporary equity	$ 461,013	$ 451,939

Balance Sheets (Parentheticals)

Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2023	Jun. 30, 2023
Preferred stock, shares par value (in Dollars per share)
Preferred stock, shares authorized	2,000,000	2,000,000
Common stock, shares par value (in Dollars per share)
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	123,156,941	123,156,941
Common stock, shares outstanding	123,156,941	123,156,941
Convertible preferred stock, Series M
Preferred stock, designated	600	600
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Total Revenue
Cost of Sales
Gross Profit
Operating Expenses:
General and administrative	3,872	12,249	7,260	61,759
Sales and marketing	126	170	580	506
Consulting expenses (including share-based compensation)	1,260	95,941	2,660	142,817
Total Operating Expenses	5,258	108,360	10,500	205,082
Operating Loss	(5,258)	(108,360)	(10,500)	(205,082)
Other Expense
Interest expense	(20,601)	(20,601)	(41,204)	(41,204)
Total Other Expense	(20,601)	(20,601)	(41,204)	(41,204)
Net Loss	(25,859)	(128,961)	(51,704)	(246,286)
Preferred Stock Dividends	(4,537)	(4,537)	(9,074)	(9,074)
Net Loss Available to Common Stockholders	$ (30,396)	$ (133,498)	$ (60,778)	$ (255,360)
Net Loss per common share:
Net Loss per common share, Basic (in Dollars per share)
Weighted average number of common shares outstanding:
Weighted average number of common shares outstanding, Basic (in Shares)	123,156,941	123,156,941	123,156,941	123,156,941

Statements of Operations (Una_2

Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net Loss per common share, Diluted
Weighted average number of common shares outstanding, Diluted	123,156,941	123,156,941	123,156,941	123,156,941

Statements of Changes in Stockh

Statements of Changes in Stockholders’ Deficit (Unaudited) - USD ($)	Common Stock	Accumulated Deficit	Total
Balance at Jun. 30, 2022	$ 133,236,117	$ (135,482,996)	$ (2,246,879)
Balance (in Shares) at Jun. 30, 2022	123,156,941
Cumulative Dividend on Series L CV Preferred		(4,537)	(4,537)
Net loss		(117,325)	(117,325)
Balance at Sep. 30, 2022	$ 133,236,117	(135,604,858)	(2,368,741)
Balance (in Shares) at Sep. 30, 2022	123,156,941
Balance at Jun. 30, 2022	$ 133,236,117	(135,482,996)	(2,246,879)
Balance (in Shares) at Jun. 30, 2022	123,156,941
Net loss			(246,286)
Balance at Dec. 31, 2022	$ 133,296,816	(135,738,356)	(2,441,540)
Balance (in Shares) at Dec. 31, 2022	123,156,941
Balance at Sep. 30, 2022	$ 133,236,117	(135,604,858)	(2,368,741)
Balance (in Shares) at Sep. 30, 2022	123,156,941
Cumulative Dividend on Series L CV Preferred		(4,537)	(4,537)
Stock options expense	60,699		60,699
Net loss		(128,961)	(128,961)
Balance at Dec. 31, 2022	$ 133,296,816	(135,738,356)	(2,441,540)
Balance (in Shares) at Dec. 31, 2022	123,156,941
Balance at Jun. 30, 2023	$ 133,346,959	(135,873,814)	(2,526,855)
Balance (in Shares) at Jun. 30, 2023	123,156,941
Cumulative Dividend on Series L CV Preferred		(4,537)	(4,537)
Net loss		(25,845)	(25,845)
Balance at Sep. 30, 2023	$ 133,346,959	(135,904,196)	(2,557,237)
Balance (in Shares) at Sep. 30, 2023	123,156,941
Balance at Jun. 30, 2023	$ 133,346,959	(135,873,814)	(2,526,855)
Balance (in Shares) at Jun. 30, 2023	123,156,941
Net loss			(51,704)
Balance at Dec. 31, 2023	$ 133,346,959	(135,934,592)	(2,587,633)
Balance (in Shares) at Dec. 31, 2023	123,156,941
Balance at Sep. 30, 2023	$ 133,346,959	(135,904,196)	(2,557,237)
Balance (in Shares) at Sep. 30, 2023	123,156,941
Cumulative Dividend on Series L CV Preferred		(4,537)	(4,537)
Net loss		(25,859)	(25,859)
Balance at Dec. 31, 2023	$ 133,346,959	$ (135,934,592)	$ (2,587,633)
Balance (in Shares) at Dec. 31, 2023	123,156,941

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Statement of Cash Flows [Abstract]
Net loss	$ (51,704)	$ (246,286)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock option expense		60,699
Changes in assets and liabilities:
Decrease in royalty receivable	10,610
Increase in due from related party	(23)
Increase in prepaid expenses		(1,004)
Increase in accounts payable and accrued expenses	35,388	120,956
Total adjustments	45,975	180,651
Net cash used in operating activities	(5,729)	(65,635)
Cash flows from financing activities:
Proceeds from promissory notes, related party	4,783	67,441
Net cash provided by financing activities	4,783	67,441
Net increase (decrease) in cash and cash equivalents	(946)	1,806
Cash at the beginning of year	1,088	613
Cash at end of the period	142	2,419
Supplemental Disclosure of cash flow information:
Cash paid for interest
Cash paid for taxes

Organization and Nature of Busi

Organization and Nature of Business	6 Months Ended
	Dec. 31, 2023
Organization and Nature of Business [Abstract]
ORGANIZATION AND NATURE OF BUSINESS	(1) ORGANIZATION AND NATURE OF BUSINESS Imaging Diagnostic Systems, Inc. (the “Company” or “IDSI”) was a medical technology company that developed a new, non-invasive CT scanner called CTLM® that used a laser beam in place of ionizing X-ray for breast imaging. This technology is called Diffuse Optical Tomography. The CTLM® provided an adjunctive imaging modality to other methods of imaging the breast such as X-ray mammography, MRI and ultrasound. In the fourth quarter of fiscal 2023, the Company terminated its CTLM® business due to the lack of financing and the absence of a realistic prospect of achieving profitability after accumulating huge operating losses for many years. Since the beginning of fiscal 2024 the Company has been focused on seeking new business opportunities to replace its failed legacy business through a reverse merger transaction. While the Company has considered several opportunities, it has yet to enter into any definitive agreement and remains a shell company. Since inception in December 1993 as a Florida corporation and subsequently its reverse merger with Alkan Corp., a New Jersey Corporation on April 14, 1994, we continued operations and changed our state of incorporation from New Jersey to Florida, effective July 1, 1995. On July 7, 2023, the Company entered into a non-binding letter of intent (“LOI”) with Bright New Vision Inc. (“BNV”) regarding a proposed reverse merger transaction. Under the terms of the LOI, upon closing, BNV shareholders would own approximately 82% of IDSI’s issued and outstanding common stock, and all of IDSI’s directors and officers would be BNV affiliates. The LOI contemplated closing the transaction on or before December 31, 2023. However, because BNV did not take any further action beyond the LOI, the proposed reverse merger will not proceed.

Going Concern and Management's

Going Concern and Management's Plans	6 Months Ended
	Dec. 31, 2023
Going Concern And Managements Plans Abstract
GOING CONCERN AND MANAGEMENT’S PLANS	(2) GOING CONCERN AND MANAGEMENT’S PLANS The accompanying financial statements are prepared assuming the Company will continue as a going concern. As of December 31, 2023, the Company had an accumulated deficit of $135,934,592, a stockholders’ deficit of $2,587,633 and a working capital deficiency of $2,126,620. For the six months ended December 31, 2023, net loss totaled $51,704. The net cash used in operating activities for the six months ended December 31, 2023 totaled $5,729. These matters, along with the Company’s lack of any viable business or material financing, raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date these financial statements are issued. The ability of the Company to continue as a going concern is dependent upon acquiring a new business through a reverse merger transaction and generating sales and obtaining additional capital and financing. While the Company believes in the viability of its strategy to acquire a profitable business and raise the necessary financing, there can be no assurances to that effect. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	(3) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (a) Basis of presentation and use of estimates The financial statements are prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“U.S. GAAP”). The unaudited interim financial information furnished herein reflects all adjustments, consisting only of normal recurring items, which in the opinion of management are necessary to fairly state the Company’s financial position, results of operations and cash flows for the dates and periods presented and to make such information not misleading. The preparation of financial statements in conformity with Generally Accepted Accounting Principles in the United States requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates and assumptions also include the valuations of certain financial instruments, stock-based compensation, deferred tax assets, the outcome of litigation and tax matters, and other matters that affect the statements of financial condition and related disclosures. Actual results could differ materially from these estimates. These unaudited financial statements should be read in conjunction with the Company’s audited financial statements for the fiscal year ended June 30, 2023, contained in our Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “Commission”) on September 30, 2024. The results of operations for the six months ended December 31, 2023, are not necessarily indicative of results to be expected for any other interim period or the fiscal year ending June 30, 2024. (b) Revenue recognition The Company follows Revenue from Contracts with Customers (Topic 606) (“ASC 606”). The Company sells medical imaging products, parts, and services where permitted to independent distributors and in certain unrepresented territories directly to end-users. The Company recognizes revenue when obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Any discounts, sales incentives or similar arrangements with the customer are estimated at time of sale and deducted from revenue. Sales taxes and other similar taxes are excluded from revenue. The Company also receives royalties pursuant to a licensing relationship with Trifoil Imaging. Revenue is recognized in the reporting periods in which royalties are due to the Company. During the six months ended December 31, 2023 and 2022, there was no (c) Allowance for doubtful accounts In the event that management determines that a receivable becomes uncollectible, or events or circumstances change, which result in a temporary cessation of payments from the distributor, we will make our best estimate of probable or potential losses in our accounts receivable balance using the allowance method for each quarterly period. Management will review the receivables at the end of each fiscal year and the appropriate allowance will be made based on current available evidence and historical experience. Our allowance for doubtful accounts was $850 as of December 31, 2023 and June 30, 2023. These amounts consist of other receivables that have been fully reserved. (d) Cash and cash equivalents Holdings of highly liquid investments with original maturities of three months or less and investment in money market funds are considered to be cash equivalents by the Company. There were no cash equivalents at December 31, 2023 and June 30, 2023. (e) Concentration of Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit of $250,000. December 31, 2023 and June 30, 2023, the Company did not have cash balances in excess of the federally insured limit. The Company did not (f) Inventory Inventories, consisting principally of raw materials, work-in-process (including completed units under testing), finished goods and units placed on consignment, are carried at the lower of cost and net realizable value. Cost is determined using the first-in, first-out (FIFO) method. Raw materials consist of purchased parts, components and supplies. Work-in-process includes completed units undergoing final inspection and testing. The Company periodically reviews the value of items in inventory and records write-downs or write-offs based on its assessment of obsolete inventory. The Company maintains an allowance for obsolete inventory and generally makes inventory value adjustments against the allowance. (g) Property and equipment Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are computed using straight-line methods over the estimated useful lives of the related assets. Expenditures for renewals and betterments which increase the estimated useful life or capacity of the asset are capitalized; expenditures for repairs and maintenance are expensed when incurred. (h) Research and development Research and development expenses consist principally of expenditures for equipment and outside third-party consultants, raw materials which are used in testing and the development of the Company’s CTLM® device or other products and product software. The non-payroll related expenses include testing at outside laboratories, parts associated with the design of initial components and tooling costs, and other costs which do not remain with the developed CTLM® device. (i) Net loss per share The Company relies on the guidance provided by ASC 260, (“Earnings per Share”), which requires the reporting of both basic and diluted earnings per share. Basic net loss per share is determined by dividing loss available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if options or other contracts to issue common stock were exercised or converted into common stock, as long as the effect of their inclusion is not anti-dilutive. The Company had 5,075,000 and 5,075,000 options vested as of December 31, 2023 and June 30, 2023, respectively and 630,290 and 630,290 options not yet vested as of December 31, 2023 and June 30, 2023, respectively. The Company had 20 shares of Series L Convertible Preferred Stock outstanding, with each share convertible into 474 shares of common stock as of December 31, 2023 and June 30, 2023. (j) Stock-based compensation We follow ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. The Company has elected to use the Black-Scholes-Merton, or BSM, option-pricing model to estimate the fair value of its options and similar awards, which incorporates various subjective assumptions including volatility, risk-free interest rate, expected life, and dividend yield to calculate the fair value of outstanding and vested stock option awards. Compensation expense recognized in the statements of operations is based on awards ultimately expected to vest and reflects estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and the Company uses different assumptions, the Company’s stock-based compensation expense could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating the Company’s forfeiture rate, the Company analyzed its historical forfeiture rate, the remaining lives of unvested options, and the amount of vested options as a percentage of total options outstanding. If the Company’s actual forfeiture rate is materially different from its estimate, or if the Company reevaluates the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what we have recorded in the current period. No stock options were granted during six months ended December 31, 2023 and 2022. Stock options are being expensed pursuant to ASC 718. The fair value concepts were not changed significantly in ASC 718; however, in adopting this Standard, companies were given the option to choose among alternative valuation models and amortization assumptions. We elected to continue to use the Black-Scholes option pricing model and expense the options as compensation over the requisite vesting period of the grant. We will reconsider use of the Black-Scholes model if additional information becomes available in the future that indicates another model would be more appropriate, or if grants issued in future periods have characteristics that cannot be reasonably estimated using this model. See Note (15) Stock Options. (k) Long-lived assets The Company relies on the guidance provided by ASC 360 (“Property, Plant & Equipment”). ASC 360 requires companies to write down to estimated fair value long-lived assets that are impaired. The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In performing the review of recoverability, the Company estimates the future cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected future cash flows is less than the carrying amount of the assets, an impairment loss is recognized. The Company has determined that no impairment losses need to be recognized through the six months ended December 31, 2023 and 2022. (l) Income taxes The Company accounts for income taxes pursuant to the provisions of ASC 740-10, “Accounting for Income Taxes,” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provisions of the ASC 740 -10 related to, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax positions. The Company has adopted ASC 740-10-25 Definition of Settlement, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. As of the date these financials were available to be issued, tax years ended June 30, 2021 to 2024 are still potentially subject to audit by the taxing authorities. (m) Allowance for Warranties The Company warrants all products and parts supplied for a period of 12 months from the date of installation or 15 months from the date the products were shipped from IDSI, whichever occurs first. Although the Company tests its product in accordance with its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Based on the Company’s experience, the allowance for warranties was estimated based on the replacement cost of the laser and certain electronic parts. Should actual product failure rates or service costs differ from the Company’s estimates, which are based on limited historical data, where applicable, revisions to the estimated warranty liability would be required. The Company had no allowance for warranties balance as of December 31, 2023 or June 30, 2023. (n) Impact of recently issued accounting pronouncements Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption. (o) Fair Value of Financial Instruments The carrying values of cash and cash equivalents, receivables, accounts payable, short-term debt and accrued liabilities approximated their fair values due to the short maturity of these instruments. After a review of our accounts receivable, the Company has not recorded an allowance for doubtful accounts. The fair value of the Company’s debt obligations is estimated based on the quoted market prices for the same or similar issues or on current rates offered to the Company for debt of the same remaining maturities. At December 31, 2023 and June 30, 2023, the aggregate fair value of the Company’s debt obligations approximated its carrying value. The Company relies upon the guidance of ASC 820 (“Fair Value Measurements and Disclosures”). ASC 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly, transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions and risk of nonperformance. ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes three levels of inputs that may be used to measure fair value: Level 1 - Quoted prices in active markets for identical assets or liabilities Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	(4) RELATED PARTY TRANSACTIONS Related party revenues On March 22, 2018, the Board of Directors approved the execution of two agreements with Xi’an of China, an affiliated Company of IDSI. The agreements are a Know How Transfer Contract and a CTLM Know How Confidentiality Agreement. The contract, having a term of 20 years, stipulates that Xi’an will pay IDSI a know how transfer fee of 25% of revenue for CTLM product sales in their territory. There were no such sales during the six months ended December 31, 2023 and 2022. Related party fees Erhfort, LLC earned consulting fees of $0 and $51,000 for the six-month period ended December 31, 2023 and 2022, respectively. Erhfort, LLC regularly reviews the Company’s operations and reports to IDSI’s CEO who lives in China. Erhfort, LLC is a related party because it owns Company common stock directly and indirectly. David Fong, who served as the Company’s CFO through August 10, 2022 and as a consultant on an as needed basis thereafter, earned consulting fees of $1,200 and $27,858 for the six-month period ended December 31, 2023 and 2022, respectively. These fees were assigned to his affiliated business, Fong & Associates, LLC. Related party payables and accrued expenses As of December 31, 2023 and June 30, 2023, the amount of interest on related party notes due to Erhfort, LLC, which is included in accounts payable, is $278,581 and $239,260, respectively. As of December 31, 2023 and June 30, 2023, the amount of consulting fees due to Erhfort, LLC, which is included in accounts payable, is $204,000 and $204,000, respectively. As December 31, 2023 and June 30, 2023, the amount of consulting fees due to Fong & Associates, LLC, which is included in accounts payable and accrued expenses, is $327,770 and $331,070, respectively. As of December 31, 2023 and June 30, 2023, the amount of reimbursable expenses due to Fong & Associates, LLC, which is included in accounts payable, is $2,041 and $6,809, respectively. As of December 31, 2023 and June 30, 2023, the amount of interest on related party notes due to JM One Holdings, LLC, which is included in accrued expenses, is $13,373 and $11,860, respectively. JM One Holdings, LLC is an entity affiliated with David Fong. Related party debt As of December 31, 2023 and June 30, 2023, the amount in promissory notes due to related parties are $768,432 and $763,649, respectively (See Note 11).

Royalty Receivable

Royalty Receivable	6 Months Ended
	Dec. 31, 2023
Royalty Receivable [Abstract]
ROYALTY RECEIVABLE	(5) ROYALTY RECEIVABLE On June 16, 2006, the Company entered into a Royalty Agreement with Bioscan Inc. whereby the Company established a licensing relationship with Bioscan which granted Bioscan an exclusive sublicensable, royalty-bearing license to make, use, offer for sale, import and otherwise develop and commercialize products in its territory. Bioscan Inc. was subsequently purchased by TriFoil Imaging. During the six months ended December 31, 2023 and 2022, there was no royalty income. As of December 31, 2023 and June 30, 2023, the Company had royalty receivable balances of $0

Inventories

Inventories	6 Months Ended
	Dec. 31, 2023
Inventories [Abstract]
INVENTORIES	(6) INVENTORIES Inventories consisted of the following: December 31, June 30, Raw materials consisting of purchased parts, components and supplies $ - $ 92,587 Finished goods - 7,500 Total Inventory $ - $ 100,087 Allowance for Obsolete Inventory - (100,087 ) Net Inventory $ - $ - Due to the age of the inventory, lack of demand for parts and lack of sales the Company recorded a 100% allowance for all inventory during the year ended June 30, 2017. On October 16, 2023, the Company abandoned all inventory.

Prepaid Expenses and Deposits

Prepaid Expenses and Deposits	6 Months Ended
	Dec. 31, 2023
Prepaid Expenses and Deposits [Abstract]
PREPAID EXPENSES AND DEPOSITS	(7) PREPAID EXPENSES AND DEPOSITS The following is a summary of prepaid expenses: December 31, June 30, Prepaid Software $ - $ - Rent Security Deposits 53 53 Consulting Retainers 10,000 10,000 Total Prepaid expenses and Deposits $ 10,053 $ 10,053

Property and Equipment

Property and Equipment	6 Months Ended
	Dec. 31, 2023
Property and Equipment [Abstract]
PROPERTY AND EQUIPMENT	(8) PROPERTY AND EQUIPMENT The following is a summary of property and equipment, less accumulated depreciation: December 31, June 30, Useful life Computers and Equipment $ - $ 12,612 5 years Third Party Software - 10,291 5 years Clinical Equipment - 15,000 5 years Total Property & Equipment $ - $ 37,903 Less: accumulated depreciation - (37,903 ) Total Property & Equipment - Net $ - $ - Depreciation expense for the six months ended December 31, 2023 and 2022 was $0. On October 16, 2023, the Company abandoned all remaining fully depreciated fixed assets due to its status as a shell company and a lack of operational activities.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	6 Months Ended
	Dec. 31, 2023
Accounts Payable and Accrued Expenses [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	(9) ACCOUNTS PAYABLE AND ACCRUED EXPENSES As of December 31, 2023 and June 30, 2023, accounts payable and accrued expenses totaled $981,457 and $946,069 respectively, which consists of accounts payable of $956,408 and $932,723 and other accrued expenses of $25,049 and $13,346, respectively. The Company received $10,000 in connection with the LOI with Bright New Vision Inc. entered into on July 7, 2023 (Note 1). This amount was recorded as an accrued expense upon receipt and represents the initial financial commitment for anticipated expenses related to the proposed reverse merger transaction.

Accrued Payroll Taxes and Penal

Accrued Payroll Taxes and Penalties	6 Months Ended
	Dec. 31, 2023
Accrued Payroll Taxes and Penalties [Abstract]
ACCRUED PAYROLL TAXES AND PENALTIES	(10) ACCRUED PAYROLL TAXES AND PENALTIES As of December 31, 2023 and June 30, 2023, the Company owed the IRS $314,019. Accrued payroll taxes represent outstanding interest and penalties based on prior management’s failure to pay payroll taxes commencing with the quarter ending March 31, 2010. As part of new management’s restructuring plan, the Company received funds from an accredited investor to be able to make a payment to pay off the payroll tax portion of the amount owed to the IRS. The Company engaged tax counsel to manage the settlement and payment. On June 27, 2018, the IRS provided counsel with a payoff calculation table indicating that the balance of taxes due was $381,224. On June 29, 2018, Viable International Investments LLC provided a bank check in that amount to counsel and they sent the check to the IRS with a letter requesting penalty and interest abatement. The amount due at December 31, 2023 of $314,019 represents the interest and penalties. The Company has formally asked the IRS to abate all remaining interest and penalties of $314,019. The Company had a telephone conference on April 18, 2019 with the office of appeals and is waiting for further communications from the appeals officer. As of December 31, 2023, the Company’s tax counsel is in the process of reviewing recent IRS correspondence to determine appeals status and will work towards final resolutions with the IRS on all outstanding liabilities. The Company has decided to wait until all resolutions are final before making any adjustments to the balance of $314,019 owed to the IRS.

Promissory Notes _ Related Part

Promissory Notes – Related Parties	6 Months Ended
	Dec. 31, 2023
Promissory Notes – Related Party [Abstract]
PROMISSORY NOTES – RELATED PARTIES	(11) PROMISSORY NOTES – RELATED PARTIES The following table is a summary of the outstanding note balances as of December 31, 2023 and June 30, 2023. Noteholder Interest Maturity December 31, June 30, Related Party Notes: Erhfort, LLC 15% 9/30/24 $ 100,000 $ 100,000 Erhfort, LLC 15% 9/30/24 100,000 100,000 JM One Holdings, LLC 15% 9/30/24 20,000 20,000 Erhfort, LLC 15% 9/30/24 100,000 100,000 Erhfort, LLC 15% 9/30/24 100,000 100,000 Erhfort, LLC 15% 9/30/24 100,000 100,000 Erhfort, LLC 15% 9/30/24 10,000 10,000 Erhfort, LLC 15% 9/30/24 10,000 10,000 Erhfort, LLC 0% On Demand 2,260 2,260 Erhfort, LLC 0% On Demand 3,669 3,669 Erhfort, LLC 0% On Demand 1,620 1,620 Erhfort, LLC 0% On Demand 1,100 1,100 Viable International Investments, LLC 0% On Demand 7,865 7,865 Viable International Investments, LLC 0% On Demand 5,000 5,000 Viable International Investments, LLC 0% On Demand 5,000 5,000 Viable International Investments, LLC 0% On Demand 5,000 5,000 Viable International Investments, LLC 0% On Demand 5,000 5,000 Viable International Investments, LLC 0% On Demand 3,000 3,000 Viable International Investments, LLC 0% On Demand 15,000 15,000 Viable International Investments, LLC 0% On Demand 30,000 30,000 Viable International Investments, LLC 0% On Demand 10,000 10,000 Viable International Investments, LLC 0% On Demand 10,000 10,000 Viable International Investments, LLC 0% On Demand 10,000 10,000 Viable International Investments, LLC 0% On Demand 5,000 5,000 Viable International Investments, LLC 0% On Demand 10,000 10,000 Viable International Investments, LLC 0% On Demand 8,847 8,847 Viable International Investments, LLC 0% On Demand 12,768 12,768 Viable International Investments, LLC 0% On Demand 9,988 9,988 Viable International Investments, LLC 0% On Demand 7,968 7,968 Viable International Investments, LLC 0% On Demand 6,968 6,968 Viable International Investments, LLC 0% On Demand 7,786 7,786 Viable International Investments, LLC 0% On Demand 5,368 5,368 Viable International Investments, LLC 0% On Demand 5,488 5,488 Viable International Investments, LLC 0% On Demand 11,568 11,568 Viable International Investments, LLC 0% On Demand 6,975 6,975 Viable International Investments, LLC 0% On Demand 411 - Viable International Investments, LLC 0% On Demand 1,232 - Viable International Investments, LLC 0% On Demand 1,570 - Viable International Investments, LLC 0% On Demand 1,570 - Xi’an IDI 0% On Demand 10,411 10,411 Total Related Party Notes $ 768,432 $ 763,649 Erhfort, LLC and Viable International Investments, LLC own Company common stock directly and indirectly. JM One Holdings, LLC is an entity affiliated with the Company’s former CFO. Hence, these debts are considered related party debt. Xi’an IDI is affiliated with IDSI due to a licensing agreement. During the six months ended December 31, 2023, the Company received loan proceeds of $4,783 from Viable International Investments, LLC with an annual interest rate of 0%. During the six months ended December 31, 2022, the Company received loan proceeds of $65,181 from Viable International Investments, LLC and $2,260 from Erhfort, LLC with an annual interest rate of 0%. The Company also converted $3,669 of accounts payables into a loan from Erhfort, LLC with an annual interest rate of 0%, with no gain or loss recorded.

PPP Loan

PPP Loan	6 Months Ended
	Dec. 31, 2023
PPP Loan [Abstract]
PPP LOAN	(12) PPP LOAN The following table is a summary of the outstanding loan balances as of December 31, 2023 and June 30, 2023. Noteholder Interest Rate Maturity December 31, June 30, Truist Bank 1 % In Default $ 72,930 $ 72,930 Total 72,930 72,930 Current Portion of Loan (72,930 ) (72,930 ) Total Long-term Loan $ - $ - On May 9, 2020, the Company entered into a loan with Truist Bank, a lender pursuant to the Paycheck Protection Program of the CARES Act as administered by the SBA in the amount of $79,600. The loan, in the form of a promissory note, had an original maturity date of May 1, 2025. No additional collateral or guarantees were provided by the Company for the loan. The PPP loan provides for customary events of default. Under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, rent payments, mortgage interest and covered utilities during the 24-week period beginning on the date of loan disbursement. The Company is required to repay the entire amount of outstanding principal, along with accrued interest, as the Company is not eligible for forgiveness. The Company began to make payments, beginning October 2021, including interest accruing at an annual interest rate of 1.0% beginning on the date of disbursement. On May 17, 2022, the Company received a default and demand letter from Truist Bank in regards to the PPP loan due to non-payment. As such the remaining balance of the PPP loan became due immediately. As of December 31, 2023 and June 30, 2023, the Company recorded an accrued interest balance related to the PPP Loan of $1,297 and $926, respectively. The accrued interest is included in accounts payable and accrued expenses on the balance sheet.

Convertible Preferred Stock

Convertible Preferred Stock	6 Months Ended
	Dec. 31, 2023
Convertible Preferred Stock [Abstract]
CONVERTIBLE PREFERRED STOCK	(13) CONVERTIBLE PREFERRED STOCK The following schedule reflects the number of shares of preferred stock that have been issued and converted as of December 31, 2023: Security Date No. of Amount Date of Conversion No. of Amount Converted Balance 12/31/2023 Series L Cv Pfd 3/31/2010 35 $ 350,000 1/6/2011 15 $ 150,000 $ 200,000 Dividends 261,013 Total redemption value $ 461,013 Total Series M Cv Pfd Various 600 $ 6,000,000 1/6/2011 600 $ 6,000,000 $ -0- Dividends -0- Total redemption value $ -0- Series L Convertible Preferred Stock On March 31, 2010, a private investor converted a $350,000 short-term promissory note into 35 shares of Series L Convertible Preferred Stock. The original purchase price/stated value is $10,000 per share and dividends accrue at an annual rate of 9%. The preferred stock is convertible into 474 shares of common stock for each share of preferred stock. On January 6, 2011, the private investor converted 15 shares of Series L Convertible Preferred Stock representing a principal value of $150,000. After the conversion, the private investor held 20 shares representing a principal value of $200,000. The remaining principal value of $200,000 is presented on the balance sheet as temporary equity, as the holder has the option to redeem for cash at any time. At December 31, 2023 and June 30, 2023, there were 20 shares of Series L Convertible Preferred Stock outstanding. At December 31, 2023 and June 30, 2023, the balance of cumulative dividends owed to the investor which is included in redemption value was $261,013 and $251,939, respectively. The total presented on the balance sheet as temporary equity is $461,013 as of December 31, 2023 and $451,939 as of June 30, 2023. Series M Convertible Preferred Stock The Company had previously sold 600 Series M Convertible Preferred Stock to Viable International Investments, LLC, a Florida limited liability company, (“Viable”). Each share of the Series M Preferred Stock was convertible into 147,283 shares of Common Stock. In the event of a liquidation, the holders of the Series M Preferred Stock would have been entitled to receive, prior to any distribution of assets to holders of Common Stock or other class of capital stock or other equity securities of the Corporation, $10,000 per share of Series M Preferred Stock held plus accrued but unpaid dividends. The holders of the Series M Preferred Stock would have had identical voting rights as any holder of Common Stock and would have voted together, not as separate classes. The original purchase price/stated value of each share of Series M Preferred Stock was $10,000 and Viable was be entitled to receive cumulative dividends at the fixed rate of 9% of the stated value per share per annum. On November 21, 2017, Viable converted 3 shares of its Series M Preferred Stock to 441,878 shares of restricted common stock. On April 18, 2017, Viable converted 6 shares of its Series M Preferred Stock to 883,696 shares of restricted common stock, and on August 7, 2018, Viable converted its remaining 591 shares of Series M Preferred Stock into 87,044,089 shares of restricted common stock. At December 31, 2023 and June 30, 2023, there were 0 shares Series M Preferred Stock outstanding. At December 31, 2023 and June 30, 2023, the balance of Series M Preferred Stock was $0.

Common Stock

Common Stock	6 Months Ended
	Dec. 31, 2023
Common Stock [Abstract]
COMMON STOCK	(14) COMMON STOCK The Company has 500,000,000 of common shares no The Company did not issue any shares of common or preferred stock during the six months ended December 31, 2023 and 2022.

Stock Options

Stock Options	6 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
STOCK OPTIONS	(15) STOCK OPTIONS On December 4, 2016, the Board of Directors adopted the Company’s 2016 Equity Incentive Plan (the “2016 Plan”) which was subsequently approved and adopted by majority written consent in lieu of an annual meeting. The purpose of the 2016 Plan is to encourage and enable the officers, employees, directors and other key persons (including consultants) of the Company, upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business, to acquire a proprietary interest in the Company. It is anticipated that providing such persons with a direct stake in the Company’s welfare will assure a closer identification of their interests with those of the Company and its stockholders, thereby stimulating their efforts on the Company’s behalf and strengthening their desire to remain with the Company. In computing the impact of stock option grants, the fair value of each option is estimated on the date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk-free interest rate; volatility of a comparable company; and expected remaining lives of the awards. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and the Company uses different assumptions, the Company’s stock-based compensation expense could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. The Company cannot assess its forfeiture rate at this time due to the lack of historical data. As of As of Expected volatility 20% to 44 % 20% to 44 % Expected term 0.00 to 2.33 Years 0.5 to 2.83 Years Risk-Free interest rate 0.05% to 2.49 % 0.05% to 2.49 % Forfeiture rate 0.00 % 0.00 % Expected dividend rate 0.00 % 0.00 % At December 31, 2023, the Company has unvested and vested options under the 2016 Plan with exercise prices that range from a low of $.20 per share to a high of $.51 per share. The following table summarizes information about all of the stock options granted, exercised, expired and cancelled under the 2016 Plan at December 31, 2023 and June 30, 2023: Employees/Consultants Options Wtd. Avg. Wtd. Avg. Aggregate Outstanding at June 30, 2022 11,205,290 $ 0.30 1.39 Years $ - Granted - $ - Expired (5,500,000 ) $ (0.20 ) Exercised - $ - Cancelled - $ - Outstanding at June 30, 2023 5,705,290 $ 0.40 1.50 Years $ - Granted - $ - Expired - $ - Exercised - $ - Cancelled - $ - Outstanding at December 31, 2023 5,705,290 $ 0.40 0.99 Years $ - The following table summarizes information about vested and unvested options under the 2016 Plan at December 31, 2023 and June 30, 2023. For the six months ended December 31, 2023 and 2022 the Company recognized expenses for options that vested of $0 and $60,699, respectively: Employees/Consultants Unvested Vested and Total Outstanding at June 30, 2022 1,505,290 9,700,000 11,205,290 Granted - - - Vested and Exercisable (875,000 ) 875,000 - Cancelled - - - Expired - (5,500,000 ) (5,500,000 ) Outstanding at June 30, 2023 630,290 5,075,000 5,705,290 Granted - - - Vested and Exercisable - - - Cancelled - - - Expired - - - Outstanding at December 31, 2023 630,290 5,075,000 5,705,290 Unvested options will be expensed under the Black-Scholes options-pricing model when they vest. As of December 31, 2023 remaining options to be expensed when vested over the next year are estimated to be $68,185. At December 31, 2023, the Company has issued options pursuant to six different stock option plans, the most recent being the 2016 Plan. All the options for the previous five plans through and including the 2012 Non-Statutory Plan have expired. The tables below summarize information about these five plans: Employees/Consultants Options Wtd. Avg. Wtd. Avg. Aggregate Outstanding at June 30, 2022 12 $ 350 0.11 Years $ - Granted - $ - Exercised - $ - Cancelled (12 ) $ (350 ) Outstanding at June 30, 2023 - $ - - $ - Granted - $ - Exercised - $ - Cancelled - $ - Outstanding at December 31, 2023 - $ - - $ - Vested & Exercisable Stock Options December 31, June 30, Employee 2016 Equity Plan - - Director 2016 Equity Plan - - Employee Other Plans - - Directors and Consultants Other Plans - - Total - - The table below summarizes information about all stock options outstanding as of December 31, 2023: Outstanding Options Vested Options Range of Exercise price Number Weighted Weighted Number Weighted Weighted $0.20 - $0.51 5,705,290 $ 0.40 0.99 5,075,000 $ 0.39 0.87 Total Outstanding options 5,705,290 $ 0.40 0.99 5,075,000 $ 0.39 0.87 The Company’s common stock, symbol IMDS, was quoted on OTCmarkets.com Pink until September 25, 2014 at which time IDSI’s registration was revoked by the Securities and Exchange Commission (SEC) for failure to timely file its Quarterly and Annual Reports. The last quoted price was $0.1. Because the Company was de-registered and OTC markets did not provide a quote for IMDS, there is no public market for the Company’s shares. Given the exercise prices adjusted for the reverse split, it is highly unlikely that any employee holding pre-2016 Plan options will exercise them. The Company has sufficient authorized shares available for all outstanding option; however, if exercised, the shares will be issued with a restrictive legend because the Company was not an SEC reporting company until October 2018. Further, given its recent return to SEC reporting status, the Company is unable to file an S-8 Registration Statement to register shares issued because of option exercise pursuant to various stock option agreements.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Dec. 31, 2023
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	(16) COMMITMENTS AND CONTINGENCIES From May 2010 to June 2012, claims were made by the IRS for payment of the Company’s accrued payroll taxes, interest and penalties, which as of June 30, 2012 was $1,489,640. The Company engaged tax counsel to handle this matter and intends to fully satisfy its payroll tax obligations. On August 4, 2014, the Company’s majority shareholder Viable International Investments LLC (“Viable”) Viable purchased 250 shares of convertible preferred stock for $2,500,000, which gave them a 78.9% voting and economic interest in the Company’s capital stock representing a change in control of the Company. New management’s tax counsel negotiated a new Installment Agreement which stipulated a lump sum payment of $250,000, which was paid on September 4, 2014 and monthly installment payments of $20,000 beginning in September 2014 due on the 18 th During fiscal 2018, as part of new management’s restructuring plan, the Company received funds from an accredited investor to pay off the payroll tax portion of the amount owed to the IRS. The Company engaged tax counsel to manage the settlement and payment. On June 27, 2018, the IRS provided counsel with a payoff calculation table indicating that the balance of taxes due was $381,224. On June 29, 2018, Viable provided a bank check in that amount to counsel and they sent the check to the IRS with a letter requesting abatement of penalties and interest totaling $314,019. As of December 31, 2023, the Company’s tax counsel is in the process of reviewing the relevant IRS correspondence to determine appeals status and will work towards final resolutions with the IRS on all outstanding liabilities. The Company has decided to wait until all resolutions are final before making any adjustments to the balance of $314,019 owed to the IRS. On October 23, 2019, the Company entered into a consulting agreement (“the Agreement”) effective as of November 1, 2019, with Dr. Huabei Jiang to serve as IDSI’s Chief Scientific Consultant. Pursuant to the Agreement, Dr. Jiang agreed to focus on improving the technical performance and image quality of IDSI’s CTLM® breast imaging device. Per the Agreement, the goal of the initial project was to complete image quality improvement by November 1, 2020. A payment of $500,000 was due upon satisfactory completion of the project; however, it was never completed. On August 22, 2024, the parties formally terminated the Agreement with no amounts due to Dr. Jiang.

Subsequent Events

Subsequent Events	6 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	(17) SUBSEQUENT EVENTS On January 17, 2024, the Company received loan proceeds of $1,570 from Viable International Investments, LLC. Interest is 0% and the principal is payable on demand. On February 5, 2024, the Company received loan proceeds of $1,570 from Viable International Investments, LLC. Interest is 0% and the principal is payable on demand. On March 14, 2024, the Company received loan proceeds of $1,570 from Viable International Investments, LLC. Interest is 0% and the principal is payable on demand. On April 13, 2024, the Company received loan proceeds of $1,570 from Viable International Investments, LLC. Interest is 0% and the principal is payable on demand. On May 16, 2024, the Company received loan proceeds of $1,570 from Viable International Investments, LLC. Interest is 0% and the principal is payable on demand. On June 12, 2024, the Company received loan proceeds of $1,570 from Viable International Investments, LLC. Interest is 0% and the principal is payable on demand. On July 9, 2024, the Company received loan proceeds of $6,830 from Viable International Investments, LLC. Interest is 0% and the principal is payable on demand. On July 24, 2024, the Company received loan proceeds of $27,091 from Viable International Investments, LLC. Interest is 0% and the principal is payable on demand. On August 16, 2024, the Company received loan proceeds of $22,724 from Viable International Investments, LLC. Interest is 0% and the principal is payable on demand. On September 18, 2024, the Company received loan proceeds of $69,965 from Viable International Investments, LLC. Interest is 0% and the principal is payable on demand.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended				6 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ (25,859)	$ (25,845)	$ (128,961)	$ (117,325)	$ (51,704)	$ (246,286)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Basis of presentation and use of estimates	(a) Basis of presentation and use of estimates The financial statements are prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“U.S. GAAP”). The unaudited interim financial information furnished herein reflects all adjustments, consisting only of normal recurring items, which in the opinion of management are necessary to fairly state the Company’s financial position, results of operations and cash flows for the dates and periods presented and to make such information not misleading. The preparation of financial statements in conformity with Generally Accepted Accounting Principles in the United States requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates and assumptions also include the valuations of certain financial instruments, stock-based compensation, deferred tax assets, the outcome of litigation and tax matters, and other matters that affect the statements of financial condition and related disclosures. Actual results could differ materially from these estimates. These unaudited financial statements should be read in conjunction with the Company’s audited financial statements for the fiscal year ended June 30, 2023, contained in our Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “Commission”) on September 30, 2024. The results of operations for the six months ended December 31, 2023, are not necessarily indicative of results to be expected for any other interim period or the fiscal year ending June 30, 2024.
Revenue recognition	(b) Revenue recognition The Company follows Revenue from Contracts with Customers (Topic 606) (“ASC 606”). The Company sells medical imaging products, parts, and services where permitted to independent distributors and in certain unrepresented territories directly to end-users. The Company recognizes revenue when obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Any discounts, sales incentives or similar arrangements with the customer are estimated at time of sale and deducted from revenue. Sales taxes and other similar taxes are excluded from revenue. The Company also receives royalties pursuant to a licensing relationship with Trifoil Imaging. Revenue is recognized in the reporting periods in which royalties are due to the Company. During the six months ended December 31, 2023 and 2022, there was no
Allowance for doubtful accounts	(c) Allowance for doubtful accounts In the event that management determines that a receivable becomes uncollectible, or events or circumstances change, which result in a temporary cessation of payments from the distributor, we will make our best estimate of probable or potential losses in our accounts receivable balance using the allowance method for each quarterly period. Management will review the receivables at the end of each fiscal year and the appropriate allowance will be made based on current available evidence and historical experience. Our allowance for doubtful accounts was $850 as of December 31, 2023 and June 30, 2023. These amounts consist of other receivables that have been fully reserved.
Cash and cash equivalents	(d) Cash and cash equivalents Holdings of highly liquid investments with original maturities of three months or less and investment in money market funds are considered to be cash equivalents by the Company. There were no cash equivalents at December 31, 2023 and June 30, 2023.
Concentration of Risk	(e) Concentration of Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit of $250,000. December 31, 2023 and June 30, 2023, the Company did not have cash balances in excess of the federally insured limit. The Company did not
Inventory	(f) Inventory Inventories, consisting principally of raw materials, work-in-process (including completed units under testing), finished goods and units placed on consignment, are carried at the lower of cost and net realizable value. Cost is determined using the first-in, first-out (FIFO) method. Raw materials consist of purchased parts, components and supplies. Work-in-process includes completed units undergoing final inspection and testing. The Company periodically reviews the value of items in inventory and records write-downs or write-offs based on its assessment of obsolete inventory. The Company maintains an allowance for obsolete inventory and generally makes inventory value adjustments against the allowance.
Property and equipment	(g) Property and equipment Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are computed using straight-line methods over the estimated useful lives of the related assets. Expenditures for renewals and betterments which increase the estimated useful life or capacity of the asset are capitalized; expenditures for repairs and maintenance are expensed when incurred.
Research and development	(h) Research and development Research and development expenses consist principally of expenditures for equipment and outside third-party consultants, raw materials which are used in testing and the development of the Company’s CTLM® device or other products and product software. The non-payroll related expenses include testing at outside laboratories, parts associated with the design of initial components and tooling costs, and other costs which do not remain with the developed CTLM® device.
Net loss per share	(i) Net loss per share The Company relies on the guidance provided by ASC 260, (“Earnings per Share”), which requires the reporting of both basic and diluted earnings per share. Basic net loss per share is determined by dividing loss available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if options or other contracts to issue common stock were exercised or converted into common stock, as long as the effect of their inclusion is not anti-dilutive. The Company had 5,075,000 and 5,075,000 options vested as of December 31, 2023 and June 30, 2023, respectively and 630,290 and 630,290 options not yet vested as of December 31, 2023 and June 30, 2023, respectively. The Company had 20 shares of Series L Convertible Preferred Stock outstanding, with each share convertible into 474 shares of common stock as of December 31, 2023 and June 30, 2023.
Stock-based compensation	(j) Stock-based compensation We follow ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. The Company has elected to use the Black-Scholes-Merton, or BSM, option-pricing model to estimate the fair value of its options and similar awards, which incorporates various subjective assumptions including volatility, risk-free interest rate, expected life, and dividend yield to calculate the fair value of outstanding and vested stock option awards. Compensation expense recognized in the statements of operations is based on awards ultimately expected to vest and reflects estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and the Company uses different assumptions, the Company’s stock-based compensation expense could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating the Company’s forfeiture rate, the Company analyzed its historical forfeiture rate, the remaining lives of unvested options, and the amount of vested options as a percentage of total options outstanding. If the Company’s actual forfeiture rate is materially different from its estimate, or if the Company reevaluates the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what we have recorded in the current period. No stock options were granted during six months ended December 31, 2023 and 2022. Stock options are being expensed pursuant to ASC 718. The fair value concepts were not changed significantly in ASC 718; however, in adopting this Standard, companies were given the option to choose among alternative valuation models and amortization assumptions. We elected to continue to use the Black-Scholes option pricing model and expense the options as compensation over the requisite vesting period of the grant. We will reconsider use of the Black-Scholes model if additional information becomes available in the future that indicates another model would be more appropriate, or if grants issued in future periods have characteristics that cannot be reasonably estimated using this model. See Note (15) Stock Options.
Long-lived assets	(k) Long-lived assets The Company relies on the guidance provided by ASC 360 (“Property, Plant & Equipment”). ASC 360 requires companies to write down to estimated fair value long-lived assets that are impaired. The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In performing the review of recoverability, the Company estimates the future cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected future cash flows is less than the carrying amount of the assets, an impairment loss is recognized. The Company has determined that no impairment losses need to be recognized through the six months ended December 31, 2023 and 2022.
Income taxes	(l) Income taxes The Company accounts for income taxes pursuant to the provisions of ASC 740-10, “Accounting for Income Taxes,” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provisions of the ASC 740 -10 related to, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax positions. The Company has adopted ASC 740-10-25 Definition of Settlement, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. As of the date these financials were available to be issued, tax years ended June 30, 2021 to 2024 are still potentially subject to audit by the taxing authorities.
Allowance for Warranties	(m) Allowance for Warranties The Company warrants all products and parts supplied for a period of 12 months from the date of installation or 15 months from the date the products were shipped from IDSI, whichever occurs first. Although the Company tests its product in accordance with its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Based on the Company’s experience, the allowance for warranties was estimated based on the replacement cost of the laser and certain electronic parts. Should actual product failure rates or service costs differ from the Company’s estimates, which are based on limited historical data, where applicable, revisions to the estimated warranty liability would be required. The Company had no allowance for warranties balance as of December 31, 2023 or June 30, 2023.
Impact of recently issued accounting pronouncements	(n) Impact of recently issued accounting pronouncements Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption.
Fair Value of Financial Instruments	(o) Fair Value of Financial Instruments The carrying values of cash and cash equivalents, receivables, accounts payable, short-term debt and accrued liabilities approximated their fair values due to the short maturity of these instruments. After a review of our accounts receivable, the Company has not recorded an allowance for doubtful accounts. The fair value of the Company’s debt obligations is estimated based on the quoted market prices for the same or similar issues or on current rates offered to the Company for debt of the same remaining maturities. At December 31, 2023 and June 30, 2023, the aggregate fair value of the Company’s debt obligations approximated its carrying value. The Company relies upon the guidance of ASC 820 (“Fair Value Measurements and Disclosures”). ASC 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly, transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions and risk of nonperformance. ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes three levels of inputs that may be used to measure fair value: Level 1 - Quoted prices in active markets for identical assets or liabilities Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Dec. 31, 2023
Inventories [Abstract]
Schedule of Inventories	Inventories consisted of the following: December 31, June 30, Raw materials consisting of purchased parts, components and supplies $ - $ 92,587 Finished goods - 7,500 Total Inventory $ - $ 100,087 Allowance for Obsolete Inventory - (100,087 ) Net Inventory $ - $ -

Prepaid Expenses and Deposits (

Prepaid Expenses and Deposits (Tables)	6 Months Ended
	Dec. 31, 2023
Prepaid Expenses and Deposits [Abstract]
Schedule of Prepaid Expenses	The following is a summary of prepaid expenses: December 31, June 30, Prepaid Software $ - $ - Rent Security Deposits 53 53 Consulting Retainers 10,000 10,000 Total Prepaid expenses and Deposits $ 10,053 $ 10,053

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Dec. 31, 2023
Property and Equipment [Abstract]
Schedule of Property and Equipment, Less Accumulated Depreciation	The following is a summary of property and equipment, less accumulated depreciation: December 31, June 30, Useful life Computers and Equipment $ - $ 12,612 5 years Third Party Software - 10,291 5 years Clinical Equipment - 15,000 5 years Total Property & Equipment $ - $ 37,903 Less: accumulated depreciation - (37,903 ) Total Property & Equipment - Net $ - $ -

Promissory Notes _ Related Pa_2

Promissory Notes – Related Parties (Tables)	6 Months Ended
	Dec. 31, 2023
Promissory Notes – Related Party [Abstract]
Schedule of Outstanding Related Party Note Balances	The following table is a summary of the outstanding note balances as of December 31, 2023 and June 30, 2023. Noteholder Interest Maturity December 31, June 30, Related Party Notes: Erhfort, LLC 15% 9/30/24 $ 100,000 $ 100,000 Erhfort, LLC 15% 9/30/24 100,000 100,000 JM One Holdings, LLC 15% 9/30/24 20,000 20,000 Erhfort, LLC 15% 9/30/24 100,000 100,000 Erhfort, LLC 15% 9/30/24 100,000 100,000 Erhfort, LLC 15% 9/30/24 100,000 100,000 Erhfort, LLC 15% 9/30/24 10,000 10,000 Erhfort, LLC 15% 9/30/24 10,000 10,000 Erhfort, LLC 0% On Demand 2,260 2,260 Erhfort, LLC 0% On Demand 3,669 3,669 Erhfort, LLC 0% On Demand 1,620 1,620 Erhfort, LLC 0% On Demand 1,100 1,100 Viable International Investments, LLC 0% On Demand 7,865 7,865 Viable International Investments, LLC 0% On Demand 5,000 5,000 Viable International Investments, LLC 0% On Demand 5,000 5,000 Viable International Investments, LLC 0% On Demand 5,000 5,000 Viable International Investments, LLC 0% On Demand 5,000 5,000 Viable International Investments, LLC 0% On Demand 3,000 3,000 Viable International Investments, LLC 0% On Demand 15,000 15,000 Viable International Investments, LLC 0% On Demand 30,000 30,000 Viable International Investments, LLC 0% On Demand 10,000 10,000 Viable International Investments, LLC 0% On Demand 10,000 10,000 Viable International Investments, LLC 0% On Demand 10,000 10,000 Viable International Investments, LLC 0% On Demand 5,000 5,000 Viable International Investments, LLC 0% On Demand 10,000 10,000 Viable International Investments, LLC 0% On Demand 8,847 8,847 Viable International Investments, LLC 0% On Demand 12,768 12,768 Viable International Investments, LLC 0% On Demand 9,988 9,988 Viable International Investments, LLC 0% On Demand 7,968 7,968 Viable International Investments, LLC 0% On Demand 6,968 6,968 Viable International Investments, LLC 0% On Demand 7,786 7,786 Viable International Investments, LLC 0% On Demand 5,368 5,368 Viable International Investments, LLC 0% On Demand 5,488 5,488 Viable International Investments, LLC 0% On Demand 11,568 11,568 Viable International Investments, LLC 0% On Demand 6,975 6,975 Viable International Investments, LLC 0% On Demand 411 - Viable International Investments, LLC 0% On Demand 1,232 - Viable International Investments, LLC 0% On Demand 1,570 - Viable International Investments, LLC 0% On Demand 1,570 - Xi’an IDI 0% On Demand 10,411 10,411 Total Related Party Notes $ 768,432 $ 763,649

PPP Loan (Tables)

PPP Loan (Tables)	6 Months Ended
	Dec. 31, 2023
PPP Loan [Abstract]
Schedule of Outstanding Loan Balances	The following table is a summary of the outstanding loan balances as of December 31, 2023 and June 30, 2023. Noteholder Interest Rate Maturity December 31, June 30, Truist Bank 1 % In Default $ 72,930 $ 72,930 Total 72,930 72,930 Current Portion of Loan (72,930 ) (72,930 ) Total Long-term Loan $ - $ -

Convertible Preferred Stock (Ta

Convertible Preferred Stock (Tables)	6 Months Ended
	Dec. 31, 2023
Convertible Preferred Stock [Abstract]
Schedule of Number of Shares of Preferred Stock	The following schedule reflects the number of shares of preferred stock that have been issued and converted as of December 31, 2023: Security Date No. of Amount Date of Conversion No. of Amount Converted Balance 12/31/2023 Series L Cv Pfd 3/31/2010 35 $ 350,000 1/6/2011 15 $ 150,000 $ 200,000 Dividends 261,013 Total redemption value $ 461,013 Total Series M Cv Pfd Various 600 $ 6,000,000 1/6/2011 600 $ 6,000,000 $ -0- Dividends -0- Total redemption value $ -0-

Stock Options (Tables)

Stock Options (Tables)	6 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Estimate the Expected Forfeiture Rate and only Recognize Expense	In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. The Company cannot assess its forfeiture rate at this time due to the lack of historical data. As of As of Expected volatility 20% to 44 % 20% to 44 % Expected term 0.00 to 2.33 Years 0.5 to 2.83 Years Risk-Free interest rate 0.05% to 2.49 % 0.05% to 2.49 % Forfeiture rate 0.00 % 0.00 % Expected dividend rate 0.00 % 0.00 %
Schedule of Stock Options Granted, Exercised, Expired and Cancelled	The following table summarizes information about all of the stock options granted, exercised, expired and cancelled under the 2016 Plan at December 31, 2023 and June 30, 2023: Employees/Consultants Options Wtd. Avg. Wtd. Avg. Aggregate Outstanding at June 30, 2022 11,205,290 $ 0.30 1.39 Years $ - Granted - $ - Expired (5,500,000 ) $ (0.20 ) Exercised - $ - Cancelled - $ - Outstanding at June 30, 2023 5,705,290 $ 0.40 1.50 Years $ - Granted - $ - Expired - $ - Exercised - $ - Cancelled - $ - Outstanding at December 31, 2023 5,705,290 $ 0.40 0.99 Years $ - Employees/Consultants Options Wtd. Avg. Wtd. Avg. Aggregate Outstanding at June 30, 2022 12 $ 350 0.11 Years $ - Granted - $ - Exercised - $ - Cancelled (12 ) $ (350 ) Outstanding at June 30, 2023 - $ - - $ - Granted - $ - Exercised - $ - Cancelled - $ - Outstanding at December 31, 2023 - $ - - $ -
Schedule of Vested and Unvested Options	The following table summarizes information about vested and unvested options under the 2016 Plan at December 31, 2023 and June 30, 2023. For the six months ended December 31, 2023 and 2022 the Company recognized expenses for options that vested of $0 and $60,699, respectively: Employees/Consultants Unvested Vested and Total Outstanding at June 30, 2022 1,505,290 9,700,000 11,205,290 Granted - - - Vested and Exercisable (875,000 ) 875,000 - Cancelled - - - Expired - (5,500,000 ) (5,500,000 ) Outstanding at June 30, 2023 630,290 5,075,000 5,705,290 Granted - - - Vested and Exercisable - - - Cancelled - - - Expired - - - Outstanding at December 31, 2023 630,290 5,075,000 5,705,290
Schedule of Vested & Exercisable Stock Options	Vested & Exercisable Stock Options December 31, June 30, Employee 2016 Equity Plan - - Director 2016 Equity Plan - - Employee Other Plans - - Directors and Consultants Other Plans - - Total - -
Schedule of Stock Options Outstanding	The table below summarizes information about all stock options outstanding as of December 31, 2023: Outstanding Options Vested Options Range of Exercise price Number Weighted Weighted Number Weighted Weighted $0.20 - $0.51 5,705,290 $ 0.40 0.99 5,075,000 $ 0.39 0.87 Total Outstanding options 5,705,290 $ 0.40 0.99 5,075,000 $ 0.39 0.87

Organization and Nature of Bu_2

Organization and Nature of Business (Details)	Jul. 07, 2023
Bright New Vision Inc [Member]
Organization and Nature of Business [Line Items]
Ownership percentage	82%

Going Concern and Management'_2

Going Concern and Management's Plans (Details) - USD ($)	3 Months Ended				6 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Going Concern And Managements Plans Abstract
Accumulated deficit	$ (135,934,592)				$ (135,934,592)		$ (135,873,814)
Stockholders’ deficit	(2,587,633)	$ (2,557,237)	$ (2,441,540)	$ (2,368,741)	(2,587,633)	$ (2,441,540)	$ (2,526,855)	$ (2,246,879)
Working capital deficit					2,126,620
Net loss	$ (25,859)	$ (25,845)	$ (128,961)	$ (117,325)	(51,704)	(246,286)
Net cash used in operating activities					$ (5,729)	$ (65,635)

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2010	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2023
Summary of Significant Accounting Policies [Line Items]
Revenue from royalties
Allowance for doubtful accounts		$ 850		850		$ 850
Federal deposit insurance corporation limit						$ 250,000
Revenue
Options vested (in Shares)
Options non vested (in Shares)		630,290		630,290		630,290
Income taxes rate				50%
Cash [Member]
Summary of Significant Accounting Policies [Line Items]
Federal deposit insurance corporation limit		$ 250,000		$ 250,000
Equity Option [Member]
Summary of Significant Accounting Policies [Line Items]
Options vested (in Shares)				5,075,000		5,075,000
Series L Convertible Preferred Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Preferred stock, shares outstanding (in Shares)		20		20
Convertible shares (in Shares)	474
Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Convertible shares (in Shares)				474		474

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)		6 Months Ended
	Mar. 22, 2018	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2023
Related Party Transactions [Line Items]
Contract term	20 years
Percentage of transfer fee	25%
Consulting fees		$ 0	$ 51,000
David Fong [Member]
Related Party Transactions [Line Items]
Consulting fees		1,200	$ 27,858
Erhfort, LLC [Member]
Related Party Transactions [Line Items]
Accounts payable		278,581		$ 239,260
Erhfort, LLC One [Member]
Related Party Transactions [Line Items]
Accounts payable		204,000		204,000
Fong & Associates, LLC [Member]
Related Party Transactions [Line Items]
Accounts payable		327,770		331,070
Fong & Associates, LLC One [Member]
Related Party Transactions [Line Items]
Accounts payable		2,041		6,809
JM One Holdings, LLC [Member]
Related Party Transactions [Line Items]
Accrued expenses		13,373		11,860
Related Party [Member]
Related Party Transactions [Line Items]
Promissory notes, related party		$ 768,432		$ 763,649

Royalty Receivable (Details)

Royalty Receivable (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Royalty Receivable [Abstract]
Royalty receivable		$ 10,610

Inventories (Details)

Inventories (Details)	Dec. 31, 2023
Inventories [Abstract]
Percentage of inventory allowance	100%

Inventories (Details) - Schedul

Inventories (Details) - Schedule of Inventories - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Inventories [Abstract]
Raw materials consisting of purchased parts, components and supplies		$ 92,587
Finished goods		7,500
Total Inventory		100,087
Allowance for Obsolete Inventory		(100,087)
Net Inventory

Prepaid Expenses and Deposits_2

Prepaid Expenses and Deposits (Details) - Schedule of Prepaid Expenses - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Schedule of Prepaid Expenses [Abstract]
Prepaid Software
Rent Security Deposits	53
Consulting Retainers	10,000
Total Prepaid expenses and Deposits	$ 10,053	$ 10,053

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	6 Months Ended	18 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Property and Equipment [Abstract]
Depreciation expense	$ 0	$ 0

Property and Equipment (Detai_2

Property and Equipment (Details) - Schedule of Property and Equipment, Less Accumulated Depreciation - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Schedule of Property and Equipment, Less Accumulated Depreciation [Line Items]
Total Property & Equipment		$ 37,903
Less: accumulated depreciation		(37,903)
Total Property & Equipment - Net
Computers and Equipment [Member]
Schedule of Property and Equipment, Less Accumulated Depreciation [Line Items]
Total Property & Equipment		$ 12,612
Useful life		5 years
Third Party Software [Member]
Schedule of Property and Equipment, Less Accumulated Depreciation [Line Items]
Total Property & Equipment		$ 10,291
Useful life		5 years
Clinical Equipment [Member]
Schedule of Property and Equipment, Less Accumulated Depreciation [Line Items]
Total Property & Equipment		$ 15,000
Useful life		5 years

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Accounts Payable and Accrued Expenses [Abstract]
Accounts payable and accrued expenses	$ 981,457	$ 946,069
Accounts payable	956,408	932,723
Other accrued expenses	25,049	$ 13,346
Other receivable	$ 10,000

Accrued Payroll Taxes and Pen_2

Accrued Payroll Taxes and Penalties (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023	Jun. 27, 2018
Accrued Payroll Taxes and Penalties [Line Items]
IRS balance owed	$ 314,019	$ 314,019
Balance of taxes due			$ 381,224
Interest and penalties	314,019
Balance owed	314,019
Minimum [Member]
Accrued Payroll Taxes and Penalties [Line Items]
Interest and penalties	$ 314,019

Promissory Notes _ Related Pa_3

Promissory Notes – Related Parties (Details) - USD ($)	6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2023
Promissory Notes – Related Party [Line Items]
Gross proceeds from note payable	$ 4,783	$ 67,441
Accounts payables	$ 956,408		$ 932,723
Viable International Investments, LLC [Member]
Promissory Notes – Related Party [Line Items]
Gross proceeds from note payable		65,181
Erhfort, LLC [Member]
Promissory Notes – Related Party [Line Items]
Gross proceeds from note payable		$ 2,260
Annual interest rate	15%
Accounts payables	$ 3,669
Promissory Note Related Parties [Member]
Promissory Notes – Related Party [Line Items]
Annual interest rate	0%
Promissory Note Related Parties [Member] | Viable International Investments, LLC [Member]
Promissory Notes – Related Party [Line Items]
Annual interest rate	0%
Promissory Note Related Parties [Member] | Erhfort, LLC [Member]
Promissory Notes – Related Party [Line Items]
Annual interest rate	0%

Promissory Notes _ Related Pa_4

Promissory Notes – Related Parties (Details) - Schedule of Outstanding Related Party Note Balances - USD ($)	6 Months Ended
	Dec. 31, 2023	Jun. 30, 2023
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	15%
Maturity Date	9/30/24
Total Related Party Notes	$ 100,000	$ 100,000
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	15%
Maturity Date	9/30/24
Total Related Party Notes	$ 100,000	100,000
JM One Holdings, LLC [Member]
Related Party Notes:
Interest Rate	15%
Maturity Date	9/30/24
Total Related Party Notes	$ 20,000	20,000
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	15%
Maturity Date	9/30/24
Total Related Party Notes	$ 100,000	100,000
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	15%
Maturity Date	9/30/24
Total Related Party Notes	$ 100,000	100,000
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	15%
Maturity Date	9/30/24
Total Related Party Notes	$ 100,000	100,000
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	15%
Maturity Date	9/30/24
Total Related Party Notes	$ 10,000	10,000
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	15%
Maturity Date	9/30/24
Total Related Party Notes	$ 10,000	10,000
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 2,260	2,260
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 3,669	3,669
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 1,620	1,620
Erhfort, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 1,100	1,100
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 7,865	7,865
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 5,000	5,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 5,000	5,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 5,000	5,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 5,000	5,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 3,000	3,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 15,000	15,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 30,000	30,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 10,000	10,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 10,000	10,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 10,000	10,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 5,000	5,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 10,000	10,000
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 8,847	8,847
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 12,768	12,768
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 9,988	9,988
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 7,968	7,968
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 6,968	6,968
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 7,786	7,786
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 5,368	5,368
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 5,488	5,488
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 11,568	11,568
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 6,975	6,975
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 411
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 1,232
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 1,570
Viable International Investments, LLC [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 1,570
Xi’an IDI [Member]
Related Party Notes:
Interest Rate	0%
Maturity Date	On Demand
Total Related Party Notes	$ 10,411	10,411
Related Party [Member]
Related Party Notes:
Total Related Party Notes	$ 768,432	$ 763,649

PPP Loan (Details)

PPP Loan (Details) - PPP Loan [Member] - USD ($)			6 Months Ended
	Jun. 30, 2023	May 09, 2020	Dec. 31, 2023	Oct. 31, 2021
Short-Term Debt [Line Items]
Loan amount		$ 79,600
Maturity date		May 01, 2025
Annual interest rate				1%
Accrued interest	$ 926		$ 1,297

PPP Loan (Details) - Schedule o

PPP Loan (Details) - Schedule of Outstanding Loan Balances - USD ($)	6 Months Ended
	Dec. 31, 2023	Jun. 30, 2023
Schedule of Outstanding Loan Balances [Line Items]
Total	$ 72,930	$ 72,930
Current Portion of Loan	(72,930)	(72,930)
Total Long-term Loan
Truist Bank [Member]
Schedule of Outstanding Loan Balances [Line Items]
Interest Rate	1%
Maturity Date	In Default
Total	$ 72,930	$ 72,930

Convertible Preferred Stock (De

Convertible Preferred Stock (Details) - USD ($)		6 Months Ended
	Mar. 31, 2010	Dec. 31, 2023	Jun. 30, 2023	Aug. 07, 2018	Nov. 21, 2017	Apr. 18, 2017	Aug. 04, 2014	Jan. 06, 2011
Convertible Preferred Stock [Line Items]
Preferred shares authorized		2,000,000	2,000,000
Convertible preferred stock				87,044,089	441,878	883,696		15
Principal value (in Dollars)								$ 150,000
Shares held	20
Remaining principal value (in Dollars)	$ 200,000
Redemption value (in Dollars)		$ 261,013	$ 251,939
Temporary equity (in Dollars)		$ 461,013	$ 451,939
Convertible preferred stock							250
Series L Convertible Preferred Stock [Member]
Convertible Preferred Stock [Line Items]
Short-term promissory note (in Dollars)	$ 350,000
Preferred shares authorized	35
Preferred stock dividend per shares (in Dollars per share)	$ 10,000
Convertible shares	474
Convertible preferred stock		20	20
Principal value (in Dollars)	$ 200,000
Temporary equity (in Dollars)		$ 461,013
Preferred stock outstanding		20
Series L Convertible Preferred Stock [Member] | Promissory Note [Member]
Convertible Preferred Stock [Line Items]
Dividend rate	9%
Series M Convertible Preferred Stock [Member]
Convertible Preferred Stock [Line Items]
Preferred stock dividend per shares (in Dollars per share)		$ 10,000
Convertible preferred stock		147,283		591	3	6
Temporary equity (in Dollars)		$ 0
Convertible preferred stock		600
Other equity securities (in Dollars)		$ 10,000
Preferred stock outstanding		0	0
Series M Convertible Preferred Stock [Member] | Promissory Note [Member]
Convertible Preferred Stock [Line Items]
Dividend rate		9%
Serie M Preferred Stock [Member]
Convertible Preferred Stock [Line Items]
Preferred stock outstanding			0
Series M Preferred Stocks [Member]
Convertible Preferred Stock [Line Items]
Preferred stock outstanding		0

Convertible Preferred Stock (_2

Convertible Preferred Stock (Details) - Schedule of Number of Shares of Preferred Stock - USD ($)	6 Months Ended
	Dec. 31, 2023	Mar. 31, 2010
Series L Preferred Stock [Member]
Schedule of Number of Shares of Preferred Stock [Line Items]
No. of Shares (in Shares)		35
Amount		$ 350,000
Balance 12/31/2023	$ 461,013
Dividends	$ 261,013
Series M Preferred Stock [Member]
Schedule of Number of Shares of Preferred Stock [Line Items]
No. of Shares Converted (in Shares)	600
Balance 12/31/2023	$ 0
Dividends	$ 0
3/31/2010 [Member] | Series L Preferred Stock [Member]
Schedule of Number of Shares of Preferred Stock [Line Items]
No. of Shares (in Shares)	35
Amount	$ 350,000
Date of Conversion	Jan. 06, 2011
No. of Shares Converted (in Shares)	15
Amount Converted	$ 150,000
Balance 12/31/2023	$ 200,000
Various Date [Member] | Series M Preferred Stock [Member]
Schedule of Number of Shares of Preferred Stock [Line Items]
No. of Shares (in Shares)	600
Amount	$ 6,000,000
Date of Conversion	Jan. 06, 2011
No. of Shares Converted (in Shares)	600
Amount Converted	$ 6,000,000
Balance 12/31/2023	$ 0

Common Stock (Details)

Common Stock (Details) - $ / shares	Dec. 31, 2023	Jun. 30, 2023
Common Stock [Abstract]
Common stock, shares authorized	500,000,000	500,000,000
Common stock, no par value (in Dollars per share)
Preferred stock, shares authorized	2,000,000	2,000,000

Stock Options (Details)

Stock Options (Details) - USD ($)	6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Stock Options [Abstract]
Lower range of exercise price	$ 0.20
Higher range of exercise price	$ 0.51
Expense of options vested	$ 0	$ 60,699
Estimated vesting expense	$ 68,185
Shares issued, price per share	$ 0.1

Stock Options (Details) - Sched

Stock Options (Details) - Schedule of Estimate the Expected Forfeiture Rate and only Recognize Expense	6 Months Ended	12 Months Ended
	Dec. 31, 2023	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Forfeiture rate	0%	0%
Expected dividend rate	0%	0%
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility	20%	20%
Expected term	0 years	6 months
Risk-Free interest rate	0.05%	0.05%
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility	44%	44%
Expected term	2 years 3 months 29 days	2 years 9 months 29 days
Risk-Free interest rate	2.49%	2.49%

Stock Options (Details) - Sch_2

Stock Options (Details) - Schedule of Stock Options Granted, Exercised, Expired and Cancelled - USD ($)		6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2023	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding balance		5,705,290	11,205,290
Options, Expired			(5,500,000)
Options, Cancelled
Outstanding balance	11,205,290	5,705,290	5,705,290
2016 Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding balance	11,205,290	5,705,290
Wtd. Avg. Exercise Price, Beginning Outstanding	$ 0.3	$ 0.4
Wtd. Avg. Remaining Term, Beginning Outstanding	1 year 4 months 20 days	11 months 26 days	1 year 6 months
Aggregate Intrinsic Value, Beginning Outstanding
Options, Expired			(5,500,000)
Wtd. Avg. Exercise Price, Expired			$ (0.2)
Options, Cancelled
Wtd. Avg. Exercise Price, Cancelled
Outstanding balance		5,705,290	5,705,290
Wtd. Avg. Exercise Price,Ending Outstanding		$ 0.4	$ 0.4
Wtd. Avg. Remaining Term,Ending Outstanding	1 year 4 months 20 days	11 months 26 days	1 year 6 months
Aggregate Intrinsic Value,Ending Outstanding
Previous Five Plan Including Non-Statutory Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding balance	12
Wtd. Avg. Exercise Price, Beginning Outstanding	$ 350
Wtd. Avg. Remaining Term, Beginning Outstanding	1 month 9 days
Aggregate Intrinsic Value, Beginning Outstanding
Options, Cancelled			(12)
Wtd. Avg. Exercise Price, Cancelled			$ (350)
Outstanding balance
Wtd. Avg. Exercise Price,Ending Outstanding
Wtd. Avg. Remaining Term,Ending Outstanding	1 month 9 days
Aggregate Intrinsic Value,Ending Outstanding

Stock Options (Details) - Sch_3

Stock Options (Details) - Schedule of Vested and Unvested Options - shares	6 Months Ended	12 Months Ended
	Dec. 31, 2023	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unvested Outstanding Beginning balance	630,290
Outstanding balance	5,705,290	11,205,290
Unvested Granted
Vested and Exercisable Granted
Total Granted
Unvested Vested and Exercisable
Vested and Exercisable
Total Vested and Exercisable
Total Cancelled
Unvested Expired		5,500,000
Vested and Exercisable Expired		(5,500,000)
Total Expired		(5,500,000)
Unvested Outstanding Ending balance	630,290	630,290
Outstanding balance	5,705,290	5,705,290
Unvested [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unvested Outstanding Beginning balance	630,290	1,505,290
Unvested Granted
Vested and Exercisable Granted
Total Granted
Unvested Vested and Exercisable		(875,000)
Vested and Exercisable		875,000
Total Vested and Exercisable		875,000
Unvested Cancelled
Unvested Expired
Vested and Exercisable Expired
Total Expired
Unvested Outstanding Ending balance	630,290	630,290
Vested and Exercisable [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vested and Exercisable Outstanding Beginning balance	5,075,000	9,700,000
Unvested Granted
Vested and Exercisable Granted
Total Granted
Unvested Vested and Exercisable		(875,000)
Vested and Exercisable		875,000
Total Vested and Exercisable		875,000
Vested and Exercisable Cancelled
Unvested Expired		5,500,000
Vested and Exercisable Expired		(5,500,000)
Total Expired		(5,500,000)
Vested and Exercisable Outstanding Ending balance	5,075,000	5,075,000

Stock Options (Details) - Sch_4

Stock Options (Details) - Schedule of Vested & Exercisable Stock Options - shares	Dec. 31, 2023	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vested & Exercisable Stock Options, Total
Employee 2016 Equity Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vested & Exercisable Stock Options, Total
Director 2016 Equity Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vested & Exercisable Stock Options, Total
Employee Other Plans [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vested & Exercisable Stock Options, Total
Directors and Consultants Other Plans [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vested & Exercisable Stock Options, Total

Stock Options (Details) - Sch_5

Stock Options (Details) - Schedule of Stock Options Outstanding - Stock Options [Member]	6 Months Ended
	Dec. 31, 2023 $ / shares shares
Schedule of Stock Options Outstanding [Line Items]
Outstanding Options, Number of outstanding | shares	5,705,290
Outstanding Options, Weighted Averaged Exercise Price | $ / shares	$ 0.4
Outstanding Options, Weighted Averaged Remaining Life (Years)	11 months 26 days
Vested Options, Number of Exercisable | shares	5,075,000
Vested Options, Weighted Averaged Exercise Price | $ / shares	$ 0.39
Vested Options, Weighted Averaged Remaining Life (Years)	10 months 13 days
$0.20 - $0.51 [Member]
Schedule of Stock Options Outstanding [Line Items]
Outstanding Options, Number of outstanding | shares	5,705,290
Outstanding Options, Weighted Averaged Exercise Price | $ / shares	$ 0.4
Outstanding Options, Weighted Averaged Remaining Life (Years)	11 months 26 days
Vested Options, Number of Exercisable | shares	5,075,000
Vested Options, Weighted Averaged Exercise Price | $ / shares	$ 0.39
Vested Options, Weighted Averaged Remaining Life (Years)	10 months 13 days

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Oct. 23, 2019	Sep. 04, 2014	Aug. 04, 2014	Dec. 31, 2023	Jun. 29, 2018	Jun. 27, 2018	Jun. 30, 2012
Commitments and Contingencies [Line Items]
Accrued payroll taxes, interest and penalties							$ 1,489,640
Convertible preferred stock (in Shares)			250
Amount of convertible preferred stock			$ 2,500,000
Percentage of voting and economic interest			78.90%
Lump sum payment		$ 250,000
Balance of taxes due						$ 381,224
Balance owed adjustments				$ 314,019
Payment of satisfactory completion	$ 500,000
Viable International Investments, LLC [Member]
Commitments and Contingencies [Line Items]
Penalties and interest totaling					$ 314,019
Interest and Penalties [Member]
Commitments and Contingencies [Line Items]
Monthly installment payments		$ 20,000

Subsequent Events (Details)

Subsequent Events (Details) - Viable International Investments, LLC [Member] - USD ($)	Sep. 18, 2024	Aug. 16, 2024	Jul. 24, 2024	Jul. 09, 2024	Jun. 12, 2024	May 16, 2024	Apr. 13, 2024	Mar. 14, 2024	Feb. 05, 2024	Jan. 17, 2024
Subsequent Event [Line Items]
Interest percentage										0%
Forecast [Member]
Subsequent Event [Line Items]
Loan proceeds	$ 69,965	$ 22,724	$ 27,091	$ 6,830	$ 1,570	$ 1,570	$ 1,570	$ 1,570	$ 1,570	$ 1,570
Interest percentage	0%	0%	0%	0%	0%	0%	0%	0%	0%